VBI Poised To Take On GSK, Dynavax As Hep B Vaccination Market Takes Off

 
• By Joseph Haas
  
Hepatitis B
VBI Vaccines hopes to take on entrenched competitors with a new HBV vaccine
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from New Products

More from Scrip